Robin Eisenhut

发表

Table 7, Scoring the risk of bias for a given clinical outcome: determined by both the type and aggregate quality of studies

Ingram Olkin, Kathryn M McDonald, Vandana Sundaram, 2010 .

Appendix Table 5, Non-English language articles on key questions 2-4 indications excluded on the basis of language

Ingram Olkin, Kathryn M McDonald, Douglas K Owens, 2010 .

Table 1, Data variables available from the Premier database

Ingram Olkin, Kathryn M McDonald, Douglas K Owens, 2010 .

Table 13, Study categories by study design and use in analysis

Ingram Olkin, Kathryn M McDonald, Vandana Sundaram, 2010 .

Appendix Table 4, Clinical trials on the off-label use of rFVIIa that are registered on an online database

Douglas K Owens, Ingram Olkin, Kathryn M McDonald, 2010 .

Table 5, Criteria for assigning quality grade to individual included studies

Ingram Olkin, Kathryn M McDonald, Douglas K Owens, 2010 .

Table 9, PICOTS criteria for assessing the applicability of evidence in Key Questions 2–4

Ingram Olkin, Kathryn M McDonald, Vandana Sundaram, 2010 .

Table 10, Diagnostic hierarchy for analysis of Premier database

Ingram Olkin, Kathryn M McDonald, Douglas K Owens, 2010 .

Table 2, Use of different study types for each component of this comparative effectiveness review

Ingram Olkin, Kathryn M McDonald, Vandana Sundaram, 2010 .

Figure 1, Framework for analyzing outcomes for rFVIIa use

Ingram Olkin, Kathryn M McDonald, Vandana Sundaram, 2010 .

Table 6, The four domains of strength of evidence and their definition and scoring

Ingram Olkin, Kathryn M McDonald, Douglas K Owens, 2010 .

Appendix Table 1, Diagnostic hiearchy and ICD-9-CM diagnosis and procedure codes

Ingram Olkin, Kathryn M McDonald, Douglas K Owens, 2010 .

Table 8, Strength of evidence grading schema

Ingram Olkin, Kathryn M McDonald, Douglas K Owens, 2010 .